A Study to Evaluate the Efficacy and Safety of AD-224

A Randomization, Double-blind, Active-controlled, Multicenter, Phase 3 Trial to Evaluate the Efficacy and Safety of AD-224A and AD-224B in Patients With Essential Hypertension

The purpose of this study is to evaluate the efficacy and safety of AD-224

Condition or disease : Essential Hypertension

Inclusion Criteria:

• Signed informed consent
• Patients with Essential Hypertension
• Other inclusions applied

Exclusion Criteria:

• Patient with Secondary Hypertension
• Other exclusions applied